Nothing Special   »   [go: up one dir, main page]

Komano, 2015 - Google Patents

An invited review following the soujinkai fujiu memorial award: A cure for chronic viral infectious diseases-bridging basic science to clinical applications

Komano, 2015

View PDF
Document ID
2566770277352777911
Author
Komano J
Publication year
Publication venue
Bull Yamaguchi Med Sch

External Links

Snippet

An invited review following the Soujinkai Fujiu Memorial Award: A Cure for Chronic Viral Infectious Diseases - Bridging Basic Sc Page 1 Main Text Obtaining a cure against an infectious disease involves eliminating the pathogenic microbe from the patient. In acute viral …
Continue reading at petit.lib.yamaguchi-u.ac.jp (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences

Similar Documents

Publication Publication Date Title
Harper et al. Interferon-α subtypes in an ex vivo model of acute HIV-1 infection: expression, potency and effector mechanisms
Boasso Type I interferon at the interface of antiviral immunity and immune regulation: the curious case of HIV‐1
Bosinger et al. Type I interferon: understanding its role in HIV pathogenesis and therapy
Fenton-May et al. Relative resistance of HIV-1 founder viruses to control by interferon-alpha
Choi et al. SAMHD1 specifically restricts retroviruses through its RNase activity
Rustagi et al. Innate antiviral immune signaling, viral evasion and modulation by HIV-1
Kirchhoff Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses
Wang et al. APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells
Berg et al. T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication
Melchjorsen Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity—clues for treatments and vaccines
Cummins et al. Making sense of how HIV kills infected CD4 T cells: implications for HIV cure
Xu et al. The role of APOBECs in viral replication
Bergamaschi et al. The CDK inhibitor p21Cip1/WAF1 is induced by FcγR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages
Bergantz et al. Interplay between intrinsic and innate immunity during HIV infection
Hosseini et al. Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy
Jeang et al. Role of RNA helicases in HIV-1 replication
Hotter et al. Interferons and beyond: Induction of antiretroviral restriction factors
Soliman et al. Mechanisms of HIV-1 control
Suspene et al. Quantification of unintegrated HIV-1 DNA at the single cell level in vivo
Amoêdo et al. Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression
Grant et al. Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes
Kimsa et al. Differential expression of tripartite motif-containing family in normal human dermal fibroblasts in response to porcine endogenous retrovirus infection
Hosseini et al. APOBEC3G-augmented stem cell therapy to modulate HIV replication: A computational study
Moens et al. Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines
Niewiadomska et al. Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif